AI assistant
Microbot Medical Inc. — Director's Dealing 2012
Feb 1, 2012
33819_dirs_2012-01-31_9b88337a-a6bb-4693-89c4-bc48856a25fa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2012-01-27
Reporting Person: TSUKAMOTO ANN (EVP, Research and Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-01-27 | Common Stock | A | 130000 | $0.00 | Acquired | 198569 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2284 | Indirect |
| Common Stock | 8853 | Indirect |
Footnotes
F1: Restricted stock units, with 1/3 vesting on January 27, 2013, 1/3 vesting on January 27, 2014 and 1/3 vesting on January 27, 2015.
F2: Includes (1) 130,000 restricted stock units, with 43,333 vesting on each of January 27, 2013, January 27, 2014 and January 27, 2015; (2) 46,667 restricted stock units, with 23,333 vesting on each of June 1, 2012 and June 1, 2013; and (3) 4,667 restricted stock units, with 2,333 vesting on each of May 15, 2012 and May 15, 2013. Amounts reflect automatic adjustments under applicable benefit plans triggered by issuer's 1 for 10 reverse stock split.
F3: 2,284 shares held in trust as to which Dr. Tsukamoto disclaims beneficial ownership. Amounts reflect automatic adjustments triggered by issuer's 1 for 10 reverse stock split.
F4: Shares held in 401(k) account in accordance with issuer's employer-match policies.